Global CRISPR Market Forecast till 2025 – Aarkstore Enterprise Aarkstore Enterprise announced Latest Trending Market Research Report Titled "GLOBAL CRISPR MARKET BY APPLICATION (2017-2025)" under Biotechnology Category. Global CRISPR Market to reach USD 6000 million by 2025. The report also provide Market Growth, Industry Dynamics, Market Revenue Share.
Global CRISPR market is valued approximately USD 248 million in 2015. The growth is primarily driven by the rising demand for drug discovery and a significant rise in research spending. Further, increasing prevalence of genetic disorders due to late pregnancies and changing lifestyle patterns have drawn the significant attention of the researchers towards this emerging technology. Global CRISPR Market to reach USD 6000 million by 2025. To Get a Free Sample Report, Kindly Contact Us On: contact@aarkstore.com Due to easy availability of gene editing tools and cost-effectiveness, the technology has the highest adoption Gene Editing application. Some more applications include Genetic Engineering, Cell Line Engineering, and others. However, these applications still have restricted use due to some ethical issues. The total market revenue has been broadly segmented into application segment, End-User segment, and geography. Each of the segments is further divided as follows:
Applications:
Genome Editing Genetic Engineering Gene Library CRISPR Plasmid Human Stem Cells Genetically Modified Crops (GMO) Cell Line Engineering
End User:
Biotechnology Companies Pharmaceutical Companies Academic Institutes Research & Development Institutes
Regions:
North America U.S. Canada Europe UK Germany France Asia Pacific China India Japan Latin America Brazil Mexico
Among End-User segment Biotechnology firms and Research & Development Institutes currently captures more than 60% of total revenue share. High investments from these End-User segments are the primary driving force for the adoption this emerging technology. However, during over forecast period, Pharmaceutical firms are expected to witness highest growth rate. Significant developments in the field of pharmaceutical biotechnology are expected to generate huge opportunities in coming years.
The global market is dominated by North America region followed by Asia Pacific. The rising prevalence of infertility and genetic disorders in the Asia Pacific region are the primary driving factors. Agriculture and Animal breeding are the emerging applications in the Asian countries. North America captures approximately 38% of the total revenue share in 2015. Europe is also an emerging region for the development of this technology.
Companies covered:
Thermo Fisher Scientific Editas Medicine Caribou Biosciences, Inc. CRISPR Therapeutics A Intellia Therapeutics Inc. Cellectis Horizon Discovery PLC
Sigma-Aldrich Corporation Precision BioSciences GenScript Corporation Sangamo Therapeutics, Inc. (SGMO) Lonza Group Limited Integrated DNA Technologies New England Biolabs OriGene Technologies, Inc. Transposagen Biopharmaceuticals, Inc
View Full Market Research Reports on Market: https://www.aarkstore.com/biotechnology/981550/global-crispr-market-size-and-regional-forecast
About Aarkstore Enterprise Aarkstore curates global market research reports from various industry verticals and serves businesses worldwide. As market research report resellers, we at Aarkstore, partner with established publishers for both; syndicated data and customized reports. The market research data supplied by us is up-to-date and reliable for current day industry analysis and future market forecasts equally. Avail Market Research Reports from us and gathers critical information about customer preferences, market requirements, key drivers and challenges for your business to align your strategies with them. The comprehensive overview of the market provided will allow you to make insight-driven decisions giving you an upper hand in the competitive landscape. Contact Us: Aarkstore Enterprise +91 9987295242 | contact@aarkstore.com | www.aarkstore.com